FP7 research funding opportunities in the field of neuroscience - PowerPoint PPT Presentation

Loading...

PPT – FP7 research funding opportunities in the field of neuroscience PowerPoint presentation | free to download - id: 3d6425-NmE1N



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

FP7 research funding opportunities in the field of neuroscience

Description:

FP7 research funding opportunities in the field of neuroscience Alain Deleener - IWT National Contact Point FP7 Health for Flanders (Belgium) Brussels 30 Jan 2007 ... – PowerPoint PPT presentation

Number of Views:23
Avg rating:3.0/5.0
Slides: 39
Provided by: homesEsat7
Learn more at: http://homes.esat.kuleuven.be
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: FP7 research funding opportunities in the field of neuroscience


1
FP7 research funding opportunities in the field
of neuroscience
  • Alain Deleener - IWT
  • National Contact Point FP7 Health for Flanders
    (Belgium)

2
EU support for Research and Innovation
  • complementary programmes, from research to
    market.
  • The 55 billion Seventh Framework Programme
    supports basic and applied research activities,
    still far from the market, leverages money and
    concentrate resources on strategic research
    areas, always on the basis of technological and
    scientific excellence.
  • The Competitiveness and Innovation Framework
    Programme does not finance research, but supports
    innovation activities, provides better access to
    finance and delivers business support services in
    the regions.
  • Structural funds have just as much funding as
    FP7, however FP7 concentrates on excellence for
    competitiveness, while the Structural Funds' main
    objective is cohesion. However, there are
    synergies between these programmes.

3
FP7 Structure and Budget
EC Framework Programme is delineated into four
Specific Programmes total budget of 50.52
billion
Euratom 4,061
Cooperation
JRC (EC) 1,751
Capacities 4,097
Ideas (European Research Council)
People 4,75
Cooperation
People
32,413
7,51 Ideas

Capacities
of which Health 6.1 billion
Total FP7 budget, including EURATOM 54,582
billion
4
Collaborative research in FP7 The Cooperation
programme
  • Thematic Priorities
  • Health 6.1
  • Food, agriculture, fisheries and
    biotechnology 1.9
  • Information and communication technologies 9.1
  • Nanosciences, nanotechnologies, materials and
    new production technologies 3.5
  • Energy 2.3
  • Environment (including climate change) 1.9
  • Transport (including aeronautics) 4.2
  • Socio-economic sciences and the humanities 0.6
  • Security 10. Space 2.8
  • Total for collaborative research 32.4
    billion

5
Cooperation Tools
  • Under each theme there will be sufficient
    flexibility to address both Emerging needs and
    Unforeseen policy needs
  • Dissemination of knowledge and transfer of
    results will be supported in all thematic areas
  • Support will be implemented across all themes
    through

Collaborative research (Collaborative projects
Networks of Excellence Coordination/support
actions)
Joint Technology Initiatives
Coordination of non-Community research
programmes (ERA-NET ERA-NET Article 169)
International Cooperation
6
Collaborative research in FP7 The Cooperation
programme
  • Thematic Priorities
  • Health 6.1
  • Food, agriculture, fisheries and
    biotechnology 1.9
  • Information and communication technologies 9.1
  • Nanosciences, nanotechnologies, materials and
    new production technologies 3.5
  • Energy 2.3
  • Environment (including climate change) 1.9
  • Transport (including aeronautics) 4.2
  • Socio-economic sciences and the humanities 0.6
  • Security 10. Space 2.8
  • Total for collaborative research 32.4
    billion

7
Scope of research in the Health Theme
  • In the Health theme, the Framework programme can
    support both basic and applied research
  • This includes discovery activities, translational
    research and clinical trials (normally only phase
    I and II).

8
Health research in FP7
Pillar 2 Translating research for human health
Pillar 3 Optimising the delivery of health
care
Pillar 1 Biotechnology, generic tools
technologies for health
cross-cutting issues child health, the health
of ageing population gender-related health
issues
Health
Budget 6.1 billion over 7 years (2007-2013)
Biotech
Translational
Public Health
9
Health research in FP7 1 Biotechnology, generic
tools and technologies
  • High-throughput research technologies for
    sequencing (genotyping, phenotyping, gene
    expression) structural / functional genomics,
    bioinformatics, systems biology
  • Detection, diagnosis and monitoringtools and
    technologies for visualisation, imaging,
    detection and analysis
  • Predicting suitability, safety and efficacy of
    therapies pharmacogenomics, biomarkers,
    targeting and delivery approaches (incl.
    alternatives to animal testing), and in vivo
    methods and models
  • Innovative therapeutic approaches
    interventiongene and cell therapy, regenerative
    medicine, transplantation, immunotherapy and
    vaccines

Health
Biotech
Translational
Public Health
10
Health research in FP7 2 Translating research
for human health (1)
  • Integrating biological data and processes
  • large-scale data gathering generate data to
    elucidate the function of genes and gene
    products and their interaction in complex
    networks systems biology to develop and
    apply systems approaches to understand and
    model biological processes
  • Research on the brain and related diseases to
    better understand the integrated structure and
    dynamics of the brain, and to study brain
    diseases, incl age-related ones dementia,
    Parkinson
  • Human development and ageing to better
    understand the process of life-long development
    and healthy ageing

Health
Biotech
Translational
Public Health
11
Health research in FP7 2 Translating research
for human health (2)
  • Translational research in infectious diseases
  • drug resistance
  • HIV / AIDS, malaria, tuberculosis
  • hepatitis
  • new and re-emerging epidemics
  • Translational research in major diseases (
    20-25 of request)
  • cancer
  • cardiovascular disease
  • diabetes / obesity
  • rare diseases
  • other chronic diseases e.g. rheumatic,
    respiratory, musculo-skeletal diseases
    arthritis)

Health
Biotech
Translational
Public Health
12
Health research in FP7 3 Optimising the delivery
of health care
  • Translating clinical outcome into clinical
    practice patient safety, best clinical
    practice, decision making in clinical settings in
    primary and specialised care, foster
    application of evidence-based medicine
  • Quality, efficiency and solidarity of health
    systems
  • organizational, financial and regulatory
    aspects of health systems
  • Enhanced disease prevention and better use
  • of medicines provide scientific evidence
    for best public health measures

Health
Biotech
Translational
Public Health
13
Work programme 2010 preparation (4th
call)Roadmap
  • Strategy Paper gtgt DG and Commissioner
    (Nov.-Dec.08)
  • Reflection paper gtgt 1st PC meeting (12 January
    09)
  • Draft WP gtgt 2nd PC meeting (5 March 09 ?)
  • Draft WP gtgt Inter-service Consultation (May)
  • Draft WP gtgt PC formal opinion (June)
  • Work Programme adoption (July)
  • publication in July or September

14
Research priorities for 4th call
  • Important features
  • focus on 4 key research challenges
  • some areas closed
  • will probably be split into 2 or 3 calls
  • 2-stage submission for some areas/topics
  • focus on 4 Key Research Challenges
  • Providing tools for translational research
  • Structuring translational research in the field
    of
  • cancer
  • Structuring translational research in the field
    of
  • neurodegenerative diseases.
  • Better health for Africa

15
Funding schemes in the Health theme (4th call)
16
FP7 Health 4th call topics (1/5)
  • Biotech, tools technologies
  • 1.1 High-throughput research
  • 1. Harmonisation of phenotyping and biosampling
    for clinical research.
  • Funding scheme Large scale integrating project.

! Topics communicated with reservation !
17
FP7 Health 4th call topics (2/5)
  • Biotech, tools technologies
  • 1.2 Detection, diagnosis and monitoring
  • 1. Tools for the identification and the detection
    of biomarkers in clinical samples and patients.
  • Multimodality biomarker analysis
  • Tools for detection, isolation and functional
    characterization of complexes of interacting
    molecules for diagnostic purposes
  • Development of new quantitative imaging
    biomarker(s) for monitoring therapeutic effects
    and safety in chronic diseases
  • High throughput molecular diagnostic imaging
  • Development and implementation of quantum imaging
    of X-rays/Y-rays for diagnosis
  • Funding scheme Small or medium-scale focused
    research projects. (2-stage)

! Topics communicated with reservation !
18
FP7 Health 4th call topics (3/5)
  • Translating research for health
  • 2.1 Integrating biological data and processes
  • 2.1.2 Systems biology
  • 1. Tackling Human Diseases through Systems
    Biology Approaches.
  • Funding scheme Large-scale integrating
    projects. (2-stage)
  • 2. Creating European multidisciplinary networks
    to address systems biology of basic biological
    processes relevant to health.
  • Funding scheme Network of Excellence. (2-stage)
  • 3. Coordination and support actions in
    large-scale data gathering and systems biology.
  • Funding scheme Coordinating Action.
  • 4. Developing new and improving existing
    mathematical algorithms for systems biology.
  • Funding scheme SICA Small or medium-scaled
    focused research project

! Topics communicated with reservation !
19
FP7 Health 4th call topics (4/5)
  • Translating research for health
  • 2.2.1 Research on the Brain and related
    diseases
  • 1. Validation of strategies for treating
    addiction.
  • Funding scheme Large scale integrating
    project.
  • 2. Actions to support dissemination of scientific
    knowledge in
  • neuroscience.
  • Funding scheme Supporting Action.
  • Also considering possible initiatives linked to
    Joint Programming
  • for research on neurodegenerative diseases.

! Topics communicated with reservation !
20
FP7 Health 4th call topics (5/5)
  • Translating research for health
  • 2.2.2 Human development and ageing
  • 1. Role of early-life developmental processes in
    longevity determination.
  • Funding scheme Large-scale integrating project.
    (2-stage)
  • 2. Homeostasis in human development and its
    effects on lifespan.
  • Funding scheme Small or medium-scale focused
    research project. (2-stage)

! Topics communicated with reservation !
21
Collaborative research in FP7 The Cooperation
programme
  • Thematic Priorities
  • Health 6.1
  • Food, agriculture, fisheries and
    biotechnology 1.9
  • Information and communication technologies 9.1
  • Nanosciences, nanotechnologies, materials and
    new production technologies 3.5
  • Energy 2.3
  • Environment (including climate change) 1.9
  • Transport (including aeronautics) 4.2
  • Socio-economic sciences and the humanities 0.6
  • Security 10. Space 2.8
  • Total for collaborative research 32.4
    billion

22
FP7 ICTcall topics (1/4)
  • Challenge 2 Cognitive Systems and Robotics
  • Objective ICT-2009.2.1 Cognitive Systems and
    Robotics
  • Pertinent research may be informed by neuro-
    and behavioural sciences and determine the
    requirements basic technologies have to meet in
    order to enable creating the targeted systems.

23
FP7 ICTcall topics (2/4)
  • Challenge 4 Towards sustainable and personalised
    healthcare
  • Objective ICT-2009.5.1 Personal Health Systems
  • Target outcome b) Mental health
  • ICT based solutions for persons suffering from
    stress, depression or bipolar disorders (other
    mental disorders are not in scope).Interdisciplina
    ry research will address the parallel development
    of technological solutions, as well as new
    management or treatment models based on
    closed-loop approaches. Emphasis will be on the
    use of multiparametric monitoring systems, which
    monitor various metrics related to behaviour and
    to bodily and brain functions (e.g. activity,
    sleep, physiological and biochemical parameters).
  • Objective ICT-2009.5.3 Virtual Physiological
    Human
  • Coordination/Support action to develop an
    observatory on the achievements and evolution of
    the broader Biomedical Informatics field which
    builds on synergies between bioinformatics,
    medical informatics, and neuroinformatics. The
    action should incorporate intensive dissemination
    and training components and facilitate
    communication between projects.

24
FP7 ICTcall topics (3/4)
  • Challenge 7 ICT for Independent Living,
    Inclusion and Governance
  • Objective ICT-2009.7.2 Accessible and Assistive
    ICT
  • ICT restoring and augmenting human capabilities
    compensating for people with reduced motor
    functions or disabilities Radically new
    ICT-enabled approaches to restore and augment the
    ability of people in their daily life with a
    focus on reduced motor functions. Research should
    aim for breakthroughs in the way humans interact
    with computers and how they may overcome their
    disability and augment their capabilities.
  • The research should build on progress in
    non-invasive sensor and actuator concepts for
    brain/neuronal-computer interaction (BNCI), smart
    bio-sensors, self-learning/adaptive systems and
    advanced signal processing.

25
FP7 ICTcall topics (4/4)
  • 4.8 Future and Emerging Technologies (Open call
    cut off dates)
  • Radical breakthroughs in ICT increasingly rely on
    fresh synergies, cross-pollination and
    convergence with different scientific disciplines
    (for instance, biology, chemistry, nanoscience,
    neuro- and cognitive science, ethology, social
    science, economics) and with the arts and
    humanities.
  • Objective ICT-2009.8.4 FET proactive 4
    Human-Computer Confluence.
  • Objective ICT-2009.8.8 FET proactive 8 Brain
    Inspired ICT
  • Target outcome
  • a) Development of multi-scale models of
    information processing and communication in the
    brain and/or PNS.
  • b) Synthetic Hardware Implementations of Neural
    Circuits
  •  

26
FP7 ICTfuture calls
  • Next calls in 2009
  • in June (deadline October/November)
  • in November (deadline beginning 2010)
  • every 2 calls all topics will be open
  • FET open call with cut off dates

27
FP7 from call to project
  • Calls proposals
  • e-proposal evaluation
  • EPSS
  • ranking
  • EC decision negotiation
  • GPF-file GA
  • Project

28
Evaluation submission procedures
  • Evaluations may follow a single or a two-step
    evaluation procedure or two-stage submission
    procedure
  • The applicable procedure will be set out in the
    call
  • Two-step evaluation procedure, only proposals
    that pass the 1st step, based on the evaluation
    against a limited set of criteria, will go
    forward for further evaluation
  • Two-stage submission procedure, only applicants
    whose proposals pass the evaluation for the 1st
    stage will be requested to submit a complete
    proposal in the 2nd stage

29
Who can participate?
  • Any undertaking, university or research centre or
    other legal entity, whether established in a
  • Member State (MS)
  • Associated country (Ac) , or
  • third country
  • Joint Research Centre (JRC) - is deemed to be
    established in another MS or Ac
  • International organisations and participants from
    third countries can participate only if in
    addition to the minima

30
Conditions for participation
  • Minimum condition, general rule, at least 3
    independent participants from 3 different MS or
    Ac
  • Additional conditions can be established by the
    SP or WP (number or type of participant, place of
    establishment)
  • Specific conditions may also apply for
  • Frontier research actions, at least 1 legal
    entity established in a MS or Ac
  • Collaborative projects addressing the
    participation of International Cooperation
    Partner Countries (ICPC) minimum is 4
    participants, 2 of which from MS or Ac and
    another 2 from ICPC countries unless otherwise
    foreseen in the WP

31
Criteria for evaluation
  • The Commission will evaluate the proposals
    submitted according to the following main
    criteria
  • Scientific and/or technological excellence
  • relevance to the topic of the call
  • quality and efficiency of the implementation and
    management
  • potential impact of project results
  • Additional requirements on the application of
    these criteria may be added in the work
    programmes
  • For research actions under the IDEAS Programme
    the sole criterion of excellence will apply

32
Eligibility for funding
  • Legal entities from MS and Ac or created under
    Community law and the JRC
  • International European interest organisations
  • Legal entities established in international
    cooperation partner countries (ICPC), and
  • International organisations and legal entities
    from third countries other than ICPC only if
  • provided for in SP or WP or
  • their contribution is essential for carrying out
    action or
  • provision for funding is provided for in a
    bilateral agreement between Community and the
    third country

33
Upper funding limits
  • Reimbursement will be according to the type of
    action and/or activity
  • Research and technological development
    activities up to 50 of eligible costs, or up to
    75 for
  • Non profit public bodies
  • secondary and higher education establishments
  • research organisations
  • SMEs
  • Security related research, for highly reliable
    capabilities with impact on security of European
    citizens and targeted to a limited number of
    public users
  • Demonstration activities up to 50
  • Other activities including management up to 100
  • Actions that will be reimbursed up to 100
  • Frontier research
  • Coordination and support
  • Training and career development of researchers

34
Reimbursement of eligible costs
  • Most funding schemes use reimbursement of
    eligible costs
  • Eligible
  • actual (average personnel costs may be used if do
    not differ significantly from actual)
  • incurred during duration of project
  • in accordance with the beneficiary usual
    accounting and management principles
  • recorded in the accounts of beneficiary
  • used for the sole purpose of achieving the
    objectives of the project
  • Non-eligible (identifiable indirect taxes
    including VAT)

35
Indirect Cost
  • Participants may charge eligible direct and
    indirect costs
  • Reimbursement of indirect costs
  • For all
  • either actual overhead, or simplified method, or
  • flat rate of 20 of direct costs
  • For Non profit Public Bodies, Secondary and
    Higher Education establishments, Research
    Organisations, and SMEs unable to identify real
    indirect costs, may apply for a flat rate of 60
    for funding schemes with Research, Technological
    Development Demonstration
  • For Coordination and Support Actions limit of
  • 7 of direct costs

36
How to use FP7 Do and dont
  • Match your objectives with the Programme funding
    opportunities. Have a clear vision of what you
    want to get.
  • Do it only if it corresponds to your strategic
    goals.
  • Use the various supporting options.

37
Consortium size and composition
  • There is no ideal size
  • whether it is for small, medium or large
    proposals, the consortium must be composed of the
    right set of competences and resources
  • large Integrating projects do not necessarily
    require large consortia
  • there are not political / geographical
    requirements, although there should not be
    obvious imbalances eg 5 out of 7 partners from
    same country

38
Key factors for success in applying for FP7
funding
  • Competition is tough only the best projects get
    funded
  • The proposal must be in scope with the topic
    and the work programme (not wishful thinking)
  • The consortium of partners must be excellent
    and appropriate for the task (select the right
    partners)
  • The proposal must address all 3 criteria
  • Convince the evaluators (dont rely on
    reputation)
  • and, of course, respect the basic rules
    (deadlines, n participants, ceilings, length,
    ethics, )
About PowerShow.com